12:00 AM
 | 
May 04, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SSR180575: Development discontinued

sanofi-aventis discontinued development of SSR180575, which was in Phase II testing, due to a...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >